Black Rock Inc. Ardelyx, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 17,552,560 shares of ARDX stock, worth $98.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,552,560
Previous 17,096,038
2.67%
Holding current value
$98.3 Million
Previous $125 Million
4.22%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ARDX
# of Institutions
221Shares Held
167MCall Options Held
517KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA16MShares$89.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$84.3 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$65.3 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$64.2 Million0.06% of portfolio
-
Marshall Wace, LLP London, X011.3MShares$63 Million0.05% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $866M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...